Cell and Gene Therapy Insights
Cell and Gene Therapy Insights is an online, open access, peer-reviewed journal with a translational focus. Key scientific, regulatory, business and manufacturing challenges and advances are addressed through publication of original research, editorials and interviews. These are complimented by daily news, webinars, and commercial and clinical trial updates.
The Medicine Maker
The development and manufacture of small molecules, biologics, and advanced therapies draws on the talent, passion and experience of a wide range of professionals. The Medicine Maker is a global publication that brings these people into the limelight, showcasing the pharma industry’s success stories and examining its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the drug development and manufacturing industry forward.
Endpoints News is an independent news organization, reporting and analyzing the top global biopharma R&D news of the day — for professionals discovering, developing, and marketing biopharmaceutical drugs.
MabDesign is a French non-profit membership organization that aims to federate, mobilize and support the development of the industrial sector in the field of immunotherapy.
MabDesign provides strategic leverage and development opportunities for its members, through the creation of a unique directory of stakeholders; by developing specialized training solutions, by providing business development and marketing support; as well as the organisation and support of scientific events, thus promoting networking and innovation.
MabDesign already counts with 160+ members companies, both pharmaceutical and biotechnology industries, service providers, training organizations and equipment suppliers at the front line of technology innovation.
Gene Therapy Net
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.